ProShare Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Sell |
25,018
-1,620
| -6% | -$15.2K | ﹤0.01% | 1616 |
|
|
2025
Q1 | $189K | Sell |
26,638
-6,766
| -20% | -$48.1K | ﹤0.01% | 1706 |
|
|
2024
Q4 | $389K | Buy |
33,404
+9,196
| +38% | +$107K | ﹤0.01% | 1439 |
|
|
2024
Q3 | $497K | Buy |
24,208
+6,245
| +35% | +$128K | ﹤0.01% | 1141 |
|
|
2024
Q2 | $402K | Sell |
17,963
-5,272
| -23% | -$118K | ﹤0.01% | 1098 |
|
|
2024
Q1 | $639K | Buy |
23,235
+2,466
| +12% | +$67.8K | ﹤0.01% | 957 |
|
|
2023
Q4 | $633K | Buy |
20,769
+3,326
| +19% | +$101K | ﹤0.01% | 905 |
|
|
2023
Q3 | $552K | Buy |
17,443
+49
| +0.3% | +$1.55K | ﹤0.01% | 876 |
|
|
2023
Q2 | $709K | Buy |
17,394
+1,111
| +7% | +$45.3K | ﹤0.01% | 812 |
|
|
2023
Q1 | $607K | Sell |
16,283
-2,452
| -13% | -$91.4K | ﹤0.01% | 846 |
|
|
2022
Q4 | $654K | Buy |
18,735
+2,819
| +18% | +$98.4K | ﹤0.01% | 852 |
|
|
2022
Q3 | $890K | Buy |
15,916
+391
| +3% | +$21.9K | ﹤0.01% | 754 |
|
|
2022
Q2 | $804K | Sell |
15,525
-6,875
| -31% | -$356K | ﹤0.01% | 802 |
|
|
2022
Q1 | $1.63M | Sell |
22,400
-5,052
| -18% | -$367K | ﹤0.01% | 769 |
|
|
2021
Q4 | $3.25M | Buy |
27,452
+1,302
| +5% | +$154K | 0.01% | 657 |
|
|
2021
Q3 | $3.51M | Sell |
26,150
-2,670
| -9% | -$358K | 0.01% | 586 |
|
|
2021
Q2 | $4.67M | Buy |
28,820
+4,820
| +20% | +$780K | 0.01% | 511 |
|
|
2021
Q1 | $1.93M | Buy |
24,000
+3,780
| +19% | +$303K | 0.01% | 711 |
|
|
2020
Q4 | $1.1M | Buy |
20,220
+4,621
| +30% | +$251K | ﹤0.01% | 838 |
|
|
2020
Q3 | $310K | Buy |
15,599
+1,432
| +10% | +$28.5K | ﹤0.01% | 1157 |
|
|
2020
Q2 | $298K | Buy |
+14,167
| New | +$298K | ﹤0.01% | 1228 |
|
|
2020
Q1 | – | Sell |
-15,812
| Closed | -$232K | – | 1447 |
|
|
2019
Q4 | $232K | Sell |
15,812
-1,822
| -10% | -$26.7K | ﹤0.01% | 1500 |
|
|
2019
Q3 | $235K | Buy |
17,634
+779
| +5% | +$10.4K | ﹤0.01% | 1348 |
|
|
2019
Q2 | $276K | Sell |
16,855
-2,121
| -11% | -$34.7K | ﹤0.01% | 1290 |
|
|
2019
Q1 | $324K | Buy |
18,976
+765
| +4% | +$13.1K | ﹤0.01% | 1214 |
|
|
2018
Q4 | $249K | Sell |
18,211
-3,468
| -16% | -$47.4K | ﹤0.01% | 1253 |
|
|
2018
Q3 | $620K | Sell |
21,679
-804
| -4% | -$23K | ﹤0.01% | 1015 |
|
|
2018
Q2 | $615K | Buy |
22,483
+779
| +4% | +$21.3K | ﹤0.01% | 1022 |
|
|
2018
Q1 | $458K | Sell |
21,704
-3,580
| -14% | -$75.5K | ﹤0.01% | 1134 |
|
|
2017
Q4 | $486K | Buy |
25,284
+3,969
| +19% | +$76.3K | ﹤0.01% | 1147 |
|
|
2017
Q3 | $530K | Buy |
21,315
+1,569
| +8% | +$39K | ﹤0.01% | 938 |
|
|
2017
Q2 | $316K | Sell |
19,746
-270
| -1% | -$4.32K | ﹤0.01% | 1136 |
|
|
2017
Q1 | $282K | Sell |
20,016
-4,886
| -20% | -$68.8K | ﹤0.01% | 1271 |
|
|
2016
Q4 | $326K | Buy |
+24,902
| New | +$326K | ﹤0.01% | 1312 |
|